Atlas Trials

Clinical Study of CMR to Evaluate the Effect of Ivabradine on the Improvement of Left Ventricular Remodeling in STEMI Patients After Primary PCI

Clinical trial NCT05348057 · UNKNOWN

Trial details

NCT number
NCT05348057
Sponsor
Qian geng
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Cardiovascular Diseases
Start date
2021-08-01
Primary completion
2022-09-01
Enrollment
240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.